TITLE

The co-expression of ERβ2 and IL-12Rβ2 is better prognostic factor in non-small-cell lung cancer progression

AUTHOR(S)
Liu, Zhao-guo; Lei, Yi-yan; Li, Wen-wen; Chen, Zhen-guang
PUB. DATE
September 2013
SOURCE
Medical Oncology;Sep2013, Vol. 30 Issue 3, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
89980910

 

Related Articles

  • Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients. Cappuzzo, F.; Tallini, G.; Finocchiaro, G.; Wilson, R. S.; Ligorio, C.; Giordano, L.; Toschi, L.; Incarbone, M.; Cavina, R.; Terracciano, L.; Roncalli, M.; Alloisio, M.; Varella-Garcia, M.; Franklin, W. A.; Santoro, A. // Annals of Oncology;Mar2010, Vol. 21 Issue 3, p562 

    Background: The purpose of this study is to investigate the prognostic role of insulin-like growth factor receptor 1 (IGF1R) expression in surgically resected non-small-cell lung cancer (NSCLC).

  • Editorial Comment: Recent advances in our understanding of lung cancer visceral pleural invasion and other forms of minimal invasion: implications for the next TNM classification. Butnor, Kelly J.; Travis, William D. // European Journal of Cardio-Thoracic Surgery;Feb2013, Vol. 43 Issue 2, p309 

    The author reflects on the recent advancements in the prognosis for visceral pleural invasion in lung cancer. He states that the visceral pleura (VP) act as an adverse prognostic factor in non-small-cell lung carcinoma(NSCLC). The author suggests to conduct further studies for identifying the...

  • Prognostic significance of microvascular invasion and microlymphatic permeation in non-small-cell lung cancer. Wang, Jun; Wang, Baocheng; Bi, Jingwang; Li, Kainan // European Journal of Cardio-Thoracic Surgery;Jun2013, Vol. 43 Issue 6, p1269 

    A letter to the editor is presented in response to the article "Prognostic impact of intratumoural invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?," by T. Hishida et al, published in a previous issue.

  • Reply to Wang et al. Hishida, Tomoyuki; Yoshida, Junji; Ishii, Genichiro; Nagai, Kanji // European Journal of Cardio-Thoracic Surgery;Jun2013, Vol. 43 Issue 6, p1270 

    A response by the authors to a letter to the editor about their article "Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?," published in a previous issue, is...

  • Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas. Sorbye, Sveinung W.; Kilvaer, Thomas K.; Valkov, Andrej; Donnem, Tom; Smeland, Eivind; Al-Shibli, Khalid; Bremnes, Roy M.; Busund, Lill-Tove // BMC Clinical Pathology;2013, Vol. 13 Issue 1, p1 

    Background: S-phase kinase-associated protein 2 (Skp2) is a member of mammalian F-box proteins. The purpose of this study is to clarify the prognostic significance of expression of Skp2 related to gender, estrogen receptor (ER) and progesterone receptor (PGR) in soft tissue sarcomas (STS). Skp2...

  • Coexpression of c-Met and Notch-1 correlates with poor prognosis in resected non-small-cell lung cancer. Wang, Ximing; Song, Na; Zhang, Ye; Cai, Ying; Liu, Yunpeng; Qu, Xiujuan; Li, Zhi; Li, Danni; Hou, Kezuo; Kang, Jian; Hu, Xuejun // Tumor Biology;Aug2015, Vol. 36 Issue 9, p7053 

    Despite considerable advances in chemotherapy, radiotherapy, target therapy, and biological therapy, the prognosis for those with resected non-small-cell lung cancer (NSCLC) has not substantially improved. It was recently reported that two receptors, Notch-1 and c-Met, correlate directly or...

  • Lung Cancer.  // Annals of Internal Medicine;9/21/2004, Vol. 141 Issue 6, p455 

    This article cites a study revealing the effectiveness of gefitinib, oral anti-cancer drug, in improving disease-related symptoms and inducing radiographic tumor regressions in non-small-cell lung cancer. Non-small-cell lung cancer kills more people in the United States than breast, colorectal,...

  • Prognostic significance of osteopontin expression in non-small-cell lung cancer: A meta-analysis. XUE-LIN ZOU; CHUN WANG; KE LIU; WEN NIE; ZHEN-YU DING // Molecular & Clinical Oncology;2015, Vol. 3 Issue 3, p633 

    Osteopontin (OPN) plays an important role in the progression and metastasis of cancer. However, the role of OPN as a prognostic factor in non-small-cell lung cancer (NSCLC) remains controversial. The aim of this study was to investigate the association between OPN expression and prognosis in...

  • Prognosis.  // Current Medical Literature: Lung Cancer;2007, Vol. 1 Issue 2, p61 

    The article presents studies on lung cancer prognosis. A study by M. Trivella, F. Pezzella et al published in the "Lancet Oncology" discussed the role of microvessel density as a prognostic factor in non-small-cell lung carcinoma. A study by H. Veselle, J. D. Freeman et al published in the...

  • Diagnosis and Prognosis. Gandhi, Leena; Linden, Philip; Plant, Paul // Current Medical Literature: Lung Cancer;2012, Vol. 5 Issue 4, p119 

    The article presents several studies about lung cancer. A Sequential Tarceva in Unresectable Non-Small-Cell Lung Carcinoma (NSCLC) study on the drug erlotinib showed a prolonged progression-free survival (PFS) rate in NSCLC patients. Another study determined the benefits of epidermal growth...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics